Top Markets
Coin of the day
Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS
Ранг среди акций #36527
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Цена акции
$5.34
Последняя синхронизация: 2026-08-14
Рыночная капитализация
$2.59M
Изменение (1 день)
-11.00%
Изменение (1 год)
313.95%
Страна
US
Торговля Jupiter Neurosciences, Inc. (JUNS)

Категория

История дроблений акций Jupiter Neurosciences, Inc. (JUNS)
Акции Jupiter Neurosciences, Inc. (символ: JUNS) прошли через 0 дроблений.
Последнее дробление произошло Aug 16, 2026.
Одна акция JUNS, купленная до Aug 16, 2026, сейчас соответствует 0 акциям JUNS.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE